Delayed
TEL AVIV STOCK EXCHANGE
07:24:08 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
1,602
ILa
|
-1.72%
|
|
-0.19%
|
-19.90%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,303
|
9,551
|
7,369
|
11,189
|
9,702
|
9,403
|
Enterprise Value (EV)
1 |
11,335
|
15,273
|
13,390
|
18,734
|
18,220
|
18,139
|
P/E ratio
|
10.8
x
|
8.5
x
|
24.3
x
|
11.4
x
|
8.19
x
|
13.8
x
|
Yield
|
4.96%
|
3.75%
|
5.45%
|
3.96%
|
5.13%
|
5.4%
|
Capitalization / Revenue
|
8.91
x
|
12.6
x
|
9.59
x
|
13.3
x
|
9.44
x
|
8.46
x
|
EV / Revenue
|
16
x
|
20.1
x
|
17.4
x
|
22.3
x
|
17.7
x
|
16.3
x
|
EV / EBITDA
|
18.8
x
|
23.4
x
|
20.3
x
|
32.2
x
|
22.1
x
|
20
x
|
EV / FCF
|
35.5
x
|
34.6
x
|
43.9
x
|
40.4
x
|
-152
x
|
25
x
|
FCF Yield
|
2.82%
|
2.89%
|
2.28%
|
2.48%
|
-0.66%
|
3.99%
|
Price to Book
|
1.3
x
|
1.56
x
|
1.17
x
|
1.47
x
|
1.11
x
|
1.07
x
|
Nbr of stocks (in thousands)
|
347,450
|
380,974
|
409,615
|
442,599
|
469,840
|
470,134
|
Reference price
2 |
18.14
|
25.07
|
17.99
|
25.28
|
20.65
|
20.00
|
Announcement Date
|
3/11/19
|
3/8/20
|
3/8/21
|
3/8/22
|
2/22/23
|
2/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
707.7
|
759.1
|
768.5
|
841.6
|
1,028
|
1,111
|
EBITDA
1 |
603.8
|
653.5
|
660
|
582
|
825.2
|
905.2
|
EBIT
1 |
601.9
|
650.1
|
655.3
|
577.5
|
821.8
|
901.6
|
Operating Margin
|
85.05%
|
85.64%
|
85.27%
|
68.62%
|
79.93%
|
81.16%
|
Earnings before Tax (EBT)
1 |
716.5
|
1,379
|
400.7
|
1,217
|
1,377
|
792.6
|
Net income
1 |
566.9
|
1,070
|
289.5
|
932.2
|
1,171
|
682.6
|
Net margin
|
80.11%
|
141.02%
|
37.66%
|
110.76%
|
113.91%
|
61.45%
|
EPS
2 |
1.680
|
2.950
|
0.7400
|
2.220
|
2.520
|
1.450
|
Free Cash Flow
1 |
319.7
|
441.9
|
304.9
|
463.9
|
-120
|
724.6
|
FCF margin
|
45.17%
|
58.22%
|
39.67%
|
55.13%
|
-11.67%
|
65.23%
|
FCF Conversion (EBITDA)
|
52.95%
|
67.62%
|
46.19%
|
79.72%
|
-
|
80.04%
|
FCF Conversion (Net income)
|
56.39%
|
41.28%
|
105.32%
|
49.77%
|
-
|
106.15%
|
Dividend per Share
2 |
0.9000
|
0.9400
|
0.9800
|
1.000
|
1.060
|
1.080
|
Announcement Date
|
3/11/19
|
3/8/20
|
3/8/21
|
3/8/22
|
2/22/23
|
2/8/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
5,033
|
5,722
|
6,021
|
7,545
|
8,517
|
8,736
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.335
x
|
8.757
x
|
9.123
x
|
12.96
x
|
10.32
x
|
9.651
x
|
Free Cash Flow
1 |
320
|
442
|
305
|
464
|
-120
|
725
|
ROE (net income / shareholders' equity)
|
12.4%
|
19.6%
|
4.66%
|
13.4%
|
14.3%
|
7.75%
|
ROA (Net income/ Total Assets)
|
3.43%
|
3.25%
|
2.9%
|
2.24%
|
2.74%
|
2.82%
|
Assets
1 |
16,528
|
32,950
|
9,972
|
41,608
|
42,779
|
24,230
|
Book Value Per Share
2 |
13.90
|
16.00
|
15.40
|
17.20
|
18.70
|
18.80
|
Cash Flow per Share
2 |
0.8600
|
0.1500
|
1.470
|
0.9600
|
1.450
|
1.110
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/11/19
|
3/8/20
|
3/8/21
|
3/8/22
|
2/22/23
|
2/8/24
|
Last Close Price
16.02
ILS Average target price
22
ILS Spread / Average Target +37.33% Consensus |